XIAP expression has been shown to be associated with aggressive clinical behavior and disease progression in many cancers [34-37], and XIAP protein levels are correlated with the sensitivities of cells to cancer therapeutic agents such as nucleosides and cytarabine [38]. This evidence concerns the gene XIAP and cancer.